Valproate semisodium

Revision as of 18:22, 27 September 2011 by WikiBot (talk | contribs) (Protected "Valproate semisodium": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Synonyms / Brand Names: Divalproex sodium, Valproate semisodium, Depakote, Depakote CP, Depakote ER, Depakote Sprinkle, Epival

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosing and Administration

Migraine
DEPAKOTE tablets are administered orally. The recommended starting dose is 250 mg twice daily. Some patients may benefit from doses up to 1000 mg/day. In the clinical trials, there was no evidence that higher doses led to greater efficacy.

Mania
For mania, the recommended initial dose is 750 mg daily in divided doses. The maximum recommended dosage is 60 mg/kg/day. For epilepsy, patients should initiate therapy at 10 to 15 mg/kg/day. No recommendation regarding the safety of valproate for use at doses above 60 mg/kg/day can be made. For migraines, the recommended starting dose is 250 mg twice daily. Some patients may benefit from doses up to 1000 mg/day.

Complex Partial Seizures
For adults and children 10 years of age or older. Monotherapy (Initial Therapy): DEPAKOTE has not been systematically studied as initial therapy. Patients should initiate therapy at 10 to 15 mg/kg/day. The dosage should be increased by 5 to 10 mg/kg/week to achieve optimal clinical response. Ordinarily, optimal clinical response is achieved at daily doses below 60 mg/kg/day. If satisfactory clinical response has not been achieved, plasma levels should be measured to determine whether or not they are in the usually accepted therapeutic range (50 to 100 μg/mL). No recommendation regarding the safety of valproate for use at doses above 60 mg/kg/day can be made. The probability of thrombocytopenia increases significantly at total trough valproate plasma concentrations above 110 μg/mL in females and 135 μg/mL in males. The benefit of improved seizure control with higher doses should be weighed against the possibility of a greater incidence of adverse reactions.

For more information on dosing please refer to Instructions for administration



FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Valproate semisodium

Return to top

Publication Resources

Most Recent Articles on Valproate semisodium

Review Articles on Valproate semisodium

Articles on Valproate semisodium in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Valproate semisodium

Return to top

Trial Resources

Ongoing Trials with Valproate semisodium at Clinical Trials.gov

Trial Results with Valproate semisodium

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Valproate semisodium

Cochrane Collaboration on Valproate semisodium

Cost Effectiveness of Valproate semisodium

Return to top

Media Resources

Powerpoint Slides on Valproate semisodium

Images of Valproate semisodium

Podcasts & MP3s on Valproate semisodium

Videos on Valproate semisodium

Return to top

Patient Resources

Patient Resources on Valproate semisodium

Discussion Groups on Valproate semisodium

Patient Handouts on Valproate semisodium

Blogs on Valproate semisodium

Valproate semisodium in the News

Valproate semisodium in the Marketplace

Return to top

International Resources

Valproate semisodium en Español

Return to top


Adapted from the FDA Package Insert.